DANIEL BILLINGS: Open Payments
NPI 1639539539 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 27 payments from 8 companies in 2025. Trend: 2023 $727 · 2024 $834 · 2025 $1,198
Food & beverage: $1,198
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $341 |
| E.R. Squibb & Sons, L.L.C. | 2 | $262 |
| PharmaEssentia USA Corporation | 3 | $208 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Alexion Pharmaceuticals, Inc. | 1 | $119 |
| Apellis Pharmaceuticals, Inc. | 3 | $68 |
| Janssen Biotech, Inc. | 2 | $47 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: OPDIVO, Fabhalta, BESREMI, PYRUKYND, ULTOMIRIS, SCEMBLIX, Empaveli, TECVAYLI.
Industry payments across NY — which companies pay providers there.
